SIMILAR PATTERNS OF AMINO ACIDS FOR 5VSD_A_SAMA3001
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 306 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 ( 2.3A) | 0.39A | 5vsdA-1pegA:6.3 | 5vsdA-1pegA:30.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1peg | HISTONE H3METHYLTRANSFERASEDIM-5 (Neurosporacrassa) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 160TRP A 161ASN A 241HIS A 242TYR A 283CYH A 308 | SAH A 319 ( 4.6A)SAH A 319 (-4.8A)SAH A 319 (-3.6A)SAH A 319 (-4.3A)SAH A 319 (-4.7A) ZN A 4 (-2.2A) | 1.18A | 5vsdA-1pegA:6.3 | 5vsdA-1pegA:30.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2h21 | RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE (Pisum sativum) |
PF00856(SET)PF09273(Rubis-subs-bind) | 5 | GLY A 81SER A 221ASN A 242HIS A 243TYR A 287 | SAM A 801 (-3.7A)SAM A 801 (-4.3A)SAM A 801 (-2.9A)SAM A 801 (-4.9A)SAM A 801 (-4.8A) | 0.52A | 5vsdA-2h21A:7.0 | 5vsdA-2h21A:19.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | GLY A 151TRP A 152ASN A 219HIS A 220TYR A 261CYH A 287 | SAM A 304 (-3.5A)NoneSAM A 304 (-3.3A)SAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 0.28A | 5vsdA-2r3aA:18.7 | 5vsdA-2r3aA:35.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2r3a | HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 151TRP A 152HIS A 220TYR A 261CYH A 289 | SAM A 304 (-3.5A)NoneSAM A 304 (-4.9A)SAM A 304 (-4.9A) ZN A 300 ( 2.3A) | 1.41A | 5vsdA-2r3aA:18.7 | 5vsdA-2r3aA:35.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | ASN A3906HIS A3907TYR A3944PHE A3946CYH A3957 | SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A)None ZN A4970 ( 2.3A) | 0.89A | 5vsdA-2w5zA:12.2 | 5vsdA-2w5zA:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w5z | HISTONE-LYSINEN-METHYLTRANSFERASEHRX (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4971 ( 3.7A)SAH A4971 (-3.1A)SAH A4971 (-4.7A)SAH A4971 (-4.9A) ZN A4970 ( 2.3A) | 0.18A | 5vsdA-2w5zA:12.2 | 5vsdA-2w5zA:29.10 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 7 | GLY A 136TRP A 137ASN A 209HIS A 210TYR A 248PHE A 286CYH A 273 | SAH A 305 (-3.8A)NoneSAH A 305 (-3.4A)NoneSAH A 305 (-4.9A)SAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 0.63A | 5vsdA-3bo5A:18.3 | 5vsdA-3bo5A:32.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3bo5 | HISTONE-LYSINEN-METHYLTRANSFERASESETMAR (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | GLY A 136TRP A 137HIS A 210TYR A 248CYH A 275 | SAH A 305 (-3.8A)NoneNoneSAH A 305 (-4.9A) ZN A 304 ( 2.3A) | 1.43A | 5vsdA-3bo5A:18.3 | 5vsdA-3bo5A:32.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Mus musculus) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5vsdA-3n71A:5.7 | 5vsdA-3n71A:16.94 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 6 | GLY A 102TRP A 103ASN A 169HIS A 170TYR A 207CYH A 219 | SAM A 237 ( 3.7A)NoneSAM A 237 (-3.3A)SAM A 237 (-4.7A)None ZN A 232 ( 2.3A) | 0.41A | 5vsdA-3ooiA:10.8 | 5vsdA-3ooiA:30.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ooi | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC (Homo sapiens) |
PF00856(SET) | 5 | GLY A 102TRP A 103HIS A 170TYR A 207CYH A 221 | SAM A 237 ( 3.7A)NoneSAM A 237 (-4.7A)None ZN A 232 (-2.3A) | 1.40A | 5vsdA-3ooiA:10.8 | 5vsdA-3ooiA:30.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 6 | GLY A2151TRP A2152ASN A2217HIS A2218TYR A2255CYH A2268 | SAM A 7 (-3.4A)NoneSAM A 7 (-3.9A)NoneNone ZN A 1 ( 2.5A) | 0.48A | 5vsdA-3opeA:14.9 | 5vsdA-3opeA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ope | PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L (Homo sapiens) |
PF00856(SET) | 5 | GLY A2151TRP A2152HIS A2218TYR A2255CYH A2270 | SAM A 7 (-3.4A)NoneNoneNone ZN A 1 (-2.7A) | 1.28A | 5vsdA-3opeA:14.9 | 5vsdA-3opeA:29.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4au7 | HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2 (Mus musculus) |
PF00856(SET) | 5 | ASN A 182HIS A 183TYR A 217PHE A 221CYH A 229 | SAH A1247 (-3.1A)SAH A1247 (-4.6A)NoneNone ZN A1248 ( 2.3A) | 0.65A | 5vsdA-4au7A:9.5 | 5vsdA-4au7A:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1561TRP A1562ASN A1628HIS A1629CYH A1678 | 0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None ZN A1803 ( 2.2A) | 0.59A | 5vsdA-4fmuA:15.1 | 5vsdA-4fmuA:28.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fmu | HISTONE-LYSINEN-METHYLTRANSFERASESETD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1561TRP A1562ASN A1628HIS A1629CYH A1680 | 0UM A1804 (-3.5A)None0UM A1804 (-3.3A)None ZN A1803 (-2.2A) | 1.47A | 5vsdA-4fmuA:15.1 | 5vsdA-4fmuA:28.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4mi5 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A 628TRP A 629ASN A 693HIS A 694TYR A 731 | None | 0.61A | 5vsdA-4mi5A:10.7 | 5vsdA-4mi5A:29.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 6 | GLY A 457TRP A 458ASN A 551HIS A 552TYR A 593CYH A 612 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)SAH A 801 (-3.2A)NoneNone ZN A 805 ( 2.4A) | 0.43A | 5vsdA-4qeoA:29.5 | 5vsdA-4qeoA:23.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qeo | HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH4 (Arabidopsisthaliana) |
PF00856(SET)PF02182(SAD_SRA)PF05033(Pre-SET) | 5 | GLY A 457TRP A 458HIS A 552TYR A 593CYH A 614 | SAH A 801 (-3.6A)SAH A 801 (-4.9A)NoneNone ZN A 805 ( 2.4A) | 1.44A | 5vsdA-4qeoA:29.5 | 5vsdA-4qeoA:23.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4w2r | ENHANCER OF ZESTE 2POLYCOMB REPRESSIVECOMPLEX 2 SUBUNIT (Anoliscarolinensis) |
no annotation | 5 | GLY A 520TRP A 521ASN A 585HIS A 586TYR A 623 | CJD A 708 (-3.6A)NoneCJD A 708 (-3.5A)NoneNone | 0.50A | 5vsdA-4w2rA:13.1 | 5vsdA-4w2rA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4z4p | HISTONE-LYSINEN-METHYLTRANSFERASE2D (Homo sapiens) |
PF00856(SET) | 5 | GLY A5408ASN A5474HIS A5475TYR A5512CYH A5525 | SAH A5602 (-3.6A)SAH A5602 (-3.1A)NoneNone ZN A5601 ( 2.2A) | 0.31A | 5vsdA-4z4pA:13.6 | 5vsdA-4z4pA:23.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zfm | PUTATIVE6-PHOSPHO-BETA-GALACTOBIOSIDASE (Geobacillusstearothermophilus) |
PF00232(Glyco_hydro_1) | 5 | GLY A 51SER A 432ASN A 53TYR A 22TRP A 38 | NoneBG6 A 501 (-3.4A)NoneNoneNone | 1.27A | 5vsdA-4zfmA:undetectable | 5vsdA-4zfmA:19.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f59 | HISTONE-LYSINEN-METHYLTRANSFERASE2C (Homo sapiens) |
PF00856(SET) | 5 | GLY A4782ASN A4848HIS A4849TYR A4886CYH A4899 | SAH A5002 (-3.5A)SAH A5002 (-2.7A)SAH A5002 (-4.6A)None ZN A5001 ( 2.0A) | 0.33A | 5vsdA-5f59A:14.1 | 5vsdA-5f59A:28.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5f6l | HISTONE-LYSINEN-METHYLTRANSFERASE2A (Homo sapiens) |
PF00856(SET) | 5 | GLY A3840ASN A3906HIS A3907TYR A3944CYH A3957 | SAH A4001 (-3.4A)SAH A4001 (-3.0A)SAH A4001 (-4.9A)SAH A4001 (-4.9A) ZN A4002 ( 2.3A) | 0.24A | 5vsdA-5f6lA:13.5 | 5vsdA-5f6lA:25.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5fbh | EXTRACELLULARCALCIUM-SENSINGRECEPTOR (Homo sapiens) |
no annotation | 5 | MET B 473GLY B 474SER B 426ASN B 472TYR B 421 | None | 1.37A | 5vsdA-5fbhB:undetectable | 5vsdA-5fbhB:18.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kjm | N-LYSINEMETHYLTRANSFERASESMYD2 (Homo sapiens) |
PF00856(SET)PF01753(zf-MYND) | 5 | GLY A 18ASN A 206HIS A 207TYR A 240CYH A 262 | SAM A 501 ( 4.1A)SAM A 501 (-3.2A)None6TM A 502 ( 3.6A) ZN A 505 (-2.3A) | 0.32A | 5vsdA-5kjmA:6.8 | 5vsdA-5kjmA:20.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ls6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,HISTONE-LYSINEN-METHYLTRANSFERASEEZH2 (Homo sapiens) |
PF00856(SET)PF11616(EZH2_WD-Binding) | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | 74D A 809 ( 3.9A)None74D A 809 (-3.0A)NoneNone | 0.73A | 5vsdA-5ls6A:11.1 | 5vsdA-5ls6A:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 6 | GLY A1074TRP A1075ASN A1141HIS A1142TYR A1179CYH A1191 | SAM A1304 ( 3.2A)NoneSAM A1304 (-2.9A)SAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 ( 2.3A) | 0.45A | 5vsdA-5lsuA:16.2 | 5vsdA-5lsuA:26.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5lsu | HISTONE-LYSINEN-METHYLTRANSFERASENSD2 (Homo sapiens) |
PF00856(SET) | 5 | GLY A1074TRP A1075HIS A1142TYR A1179CYH A1193 | SAM A1304 ( 3.2A)NoneSAM A1304 (-4.6A)SAM A1304 (-4.1A) ZN A1301 (-2.3A) | 1.39A | 5vsdA-5lsuA:16.2 | 5vsdA-5lsuA:26.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | MET A1048GLY A1049TRP A1050ASN A1112HIS A1113CYH A1170 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.4A)SAM A1505 (-4.7A) ZN A1504 (-2.2A) | 1.30A | 5vsdA-5tuyA:24.9 | 5vsdA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tuy | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 11 | MET A1048GLY A1049TRP A1050SER A1084ASN A1112HIS A1113TYR A1154PHE A1158TRP A1159PHE A1166CYH A1168 | SAM A1505 (-3.4A)SAM A1505 ( 3.9A)NoneSAM A1505 (-3.8A)SAM A1505 (-3.4A)SAM A1505 (-4.7A)SAM A1505 (-4.9A)7L6 A1506 (-4.3A)NoneSAM A1505 (-4.3A) ZN A1504 (-2.2A) | 0.34A | 5vsdA-5tuyA:24.9 | 5vsdA-5tuyA:79.07 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 6 | MET A1136GLY A1137TRP A1138HIS A1201TYR A1242CYH A1258 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-4.6A)SAM A3001 (-4.8A) ZN A3005 (-2.3A) | 1.40A | 5vsdA-5vsdA:45.2 | 5vsdA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 5 | MET A1136GLY A1137TRP A1138HIS A1202CYH A1258 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneNone ZN A3005 (-2.3A) | 1.46A | 5vsdA-5vsdA:45.2 | 5vsdA-5vsdA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5vsd | HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1 (Homo sapiens) |
PF00856(SET)PF05033(Pre-SET) | 12 | MET A1136GLY A1137TRP A1138SER A1172ASN A1200HIS A1201TYR A1242PHE A1246TRP A1247PHE A1254CYH A1256ARG A1257 | SAM A3001 (-3.4A)SAM A3001 (-3.6A)NoneSAM A3001 (-3.7A)SAM A3001 (-3.4A)SAM A3001 (-4.6A)SAM A3001 (-4.8A)9HJ A3006 ( 4.3A)NoneSAM A3001 ( 4.5A) ZN A3005 ( 2.4A)SAM A3001 (-4.3A) | 0.01A | 5vsdA-5vsdA:45.2 | 5vsdA-5vsdA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wg6 | HISTONE-LYSINEN-METHYLTRANSFERASEEZH2,POLYCOMBPROTEIN SUZ12(E.C.2.1.1.43)CHIMERA (Homo sapiens) |
no annotation | 5 | GLY A 623TRP A 624ASN A 688HIS A 689TYR A 726 | A9G A9009 ( 4.2A)NoneA9G A9009 (-3.1A)NoneNone | 0.68A | 5vsdA-5wg6A:12.5 | 5vsdA-5wg6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5xxg | - (-) |
no annotation | 5 | GLY A 15ASN A 205HIS A 206TYR A 239CYH A 261 | SAM A 502 ( 3.9A)SAM A 502 (-3.1A)None8HR A 501 ( 4.0A) ZN A 503 (-2.2A) | 0.53A | 5vsdA-5xxgA:6.4 | 5vsdA-5xxgA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 6 | GLY A1156TRP A1157ASN A1223HIS A1224TYR A1261CYH A1273 | SAM A1301 (-3.6A)NoneSAM A1301 (-3.2A)NoneSAM A1301 (-4.9A) ZN A1304 ( 2.3A) | 0.54A | 5vsdA-6cenA:16.1 | 5vsdA-6cenA:27.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6cen | HISTONE-LYSINEN-METHYLTRANSFERASENSD3 (Homo sapiens) |
no annotation | 5 | GLY A1156TRP A1157HIS A1224TYR A1261CYH A1275 | SAM A1301 (-3.6A)NoneNoneSAM A1301 (-4.9A) ZN A1304 (-2.3A) | 1.50A | 5vsdA-6cenA:16.1 | 5vsdA-6cenA:27.41 |